

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.45358211 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.45358211 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.10631866 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.97885313 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97072690 |
| 6 | * definitive hemopoiesis (GO:0060216) | 4.78692902 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.76856285 |
| 8 | Peyers patch development (GO:0048541) | 4.37103862 |
| 9 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.37103862 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.24012561 |
| 11 | viral transcription (GO:0019083) | 4.19841335 |
| 12 | megakaryocyte development (GO:0035855) | 4.15338992 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.05743752 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96602506 |
| 15 | translational termination (GO:0006415) | 3.96077971 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 3.91235442 |
| 17 | negative regulation of phagocytosis (GO:0050765) | 3.79300668 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.75855754 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.73827769 |
| 20 | aggressive behavior (GO:0002118) | 3.62380449 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.50985683 |
| 22 | mature B cell differentiation involved in immune response (GO:0002313) | 3.40410610 |
| 23 | regulation of B cell differentiation (GO:0045577) | 3.40181820 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.39687233 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39445351 |
| 26 | ribosomal small subunit biogenesis (GO:0042274) | 3.37742199 |
| 27 | tolerance induction (GO:0002507) | 3.35333947 |
| 28 | translational elongation (GO:0006414) | 3.33227353 |
| 29 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23198568 |
| 30 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.21456750 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.19833591 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19792871 |
| 33 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.17734905 |
| 34 | negative regulation of innate immune response (GO:0045824) | 3.16721098 |
| 35 | regulation of granulocyte differentiation (GO:0030852) | 3.16625887 |
| 36 | detection of bacterium (GO:0016045) | 3.16448447 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15675913 |
| 38 | mature B cell differentiation (GO:0002335) | 3.14452496 |
| 39 | interferon-gamma production (GO:0032609) | 3.14047710 |
| 40 | protein targeting to ER (GO:0045047) | 3.12716396 |
| 41 | negative thymic T cell selection (GO:0045060) | 3.12631507 |
| 42 | negative T cell selection (GO:0043383) | 3.12324151 |
| 43 | response to peptidoglycan (GO:0032494) | 3.11216071 |
| 44 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.11092020 |
| 45 | cotranslational protein targeting to membrane (GO:0006613) | 3.11066234 |
| 46 | leukocyte aggregation (GO:0070486) | 3.07818667 |
| 47 | T cell homeostasis (GO:0043029) | 3.06828051 |
| 48 | viral life cycle (GO:0019058) | 3.06577962 |
| 49 | embryonic hemopoiesis (GO:0035162) | 3.06535100 |
| 50 | maturation of SSU-rRNA (GO:0030490) | 3.05123889 |
| 51 | regulation of erythrocyte differentiation (GO:0045646) | 3.03310112 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.02988859 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02278614 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.02278614 |
| 55 | regulation of germinal center formation (GO:0002634) | 3.02147520 |
| 56 | thymic T cell selection (GO:0045061) | 3.01966402 |
| 57 | detection of other organism (GO:0098543) | 3.01901568 |
| 58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00538972 |
| 59 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.98429291 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98185926 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96948845 |
| 62 | response to muramyl dipeptide (GO:0032495) | 2.96755888 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95885500 |
| 64 | RNA destabilization (GO:0050779) | 2.95851570 |
| 65 | regulation of female receptivity (GO:0045924) | 2.95610141 |
| 66 | lymph node development (GO:0048535) | 2.95598477 |
| 67 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.95428099 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 2.94593328 |
| 69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94033497 |
| 70 | neutrophil activation (GO:0042119) | 2.93875169 |
| 71 | response to interleukin-15 (GO:0070672) | 2.92927231 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 2.90732105 |
| 73 | cellular response to interleukin-15 (GO:0071350) | 2.90419673 |
| 74 | protein localization to endoplasmic reticulum (GO:0070972) | 2.90012173 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88413705 |
| 76 | negative regulation of stress fiber assembly (GO:0051497) | 2.87841660 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 2.87749888 |
| 78 | defense response to protozoan (GO:0042832) | 2.87626062 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.87185009 |
| 80 | angiogenesis involved in wound healing (GO:0060055) | 2.83588113 |
| 81 | cellular protein complex disassembly (GO:0043624) | 2.81263054 |
| 82 | cellular response to exogenous dsRNA (GO:0071360) | 2.81208586 |
| 83 | germ cell migration (GO:0008354) | 2.80248509 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 2.79125676 |
| 85 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78991013 |
| 86 | positive regulation of T cell differentiation (GO:0045582) | 2.77721753 |
| 87 | negative regulation of bone resorption (GO:0045779) | 2.77200126 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.74279270 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 2.72944650 |
| 90 | positive regulation of B cell activation (GO:0050871) | 2.71780409 |
| 91 | female mating behavior (GO:0060180) | 2.71495911 |
| 92 | hepatocyte apoptotic process (GO:0097284) | 2.71466573 |
| 93 | T cell receptor signaling pathway (GO:0050852) | 2.70598565 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70178662 |
| 95 | regulation of interleukin-2 production (GO:0032663) | 2.70096445 |
| 96 | actin nucleation (GO:0045010) | 2.69691448 |
| 97 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.69503565 |
| 98 | T cell selection (GO:0045058) | 2.68892809 |
| 99 | positive regulation of histone deacetylation (GO:0031065) | 2.68849332 |
| 100 | positive regulation of lymphocyte differentiation (GO:0045621) | 2.68372739 |
| 101 | activated T cell proliferation (GO:0050798) | 2.67819294 |
| 102 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66491013 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66491013 |
| 104 | negative regulation of B cell apoptotic process (GO:0002903) | 2.66291549 |
| 105 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.65944096 |
| 106 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.65936376 |
| 107 | lymphocyte homeostasis (GO:0002260) | 2.65454232 |
| 108 | B cell mediated immunity (GO:0019724) | 2.63970178 |
| 109 | T cell migration (GO:0072678) | 2.63854937 |
| 110 | response to protozoan (GO:0001562) | 2.63364597 |
| 111 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.63008734 |
| 112 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.62955101 |
| 113 | cellular extravasation (GO:0045123) | 2.62677434 |
| 114 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.62513535 |
| 115 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62485222 |
| 116 | pinocytosis (GO:0006907) | 2.62159131 |
| 117 | translational initiation (GO:0006413) | 2.61582674 |
| 118 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60986147 |
| 119 | positive regulation by symbiont of host defense response (GO:0052509) | 2.60208281 |
| 120 | modulation by symbiont of host defense response (GO:0052031) | 2.60208281 |
| 121 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.60208281 |
| 122 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.60208281 |
| 123 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.60208281 |
| 124 | modulation by symbiont of host immune response (GO:0052553) | 2.60208281 |
| 125 | response to interferon-alpha (GO:0035455) | 2.60178964 |
| 126 | mast cell activation (GO:0045576) | 2.58450402 |
| 127 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.58136158 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.57458039 |
| 129 | positive regulation of granulocyte differentiation (GO:0030854) | 2.56959002 |
| 130 | protein complex disassembly (GO:0043241) | 2.56753159 |
| 131 | secretory granule organization (GO:0033363) | 2.56439906 |
| 132 | positive regulation of isotype switching (GO:0045830) | 2.53515022 |
| 133 | response to laminar fluid shear stress (GO:0034616) | 2.52934976 |
| 134 | leukocyte homeostasis (GO:0001776) | 2.52758811 |
| 135 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.51279185 |
| 136 | response to type I interferon (GO:0034340) | 2.51192912 |
| 137 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.50849567 |
| 138 | positive T cell selection (GO:0043368) | 2.50414406 |
| 139 | platelet dense granule organization (GO:0060155) | 2.50339987 |
| 140 | positive regulation of protein deacetylation (GO:0090312) | 2.49707671 |
| 141 | response to interferon-beta (GO:0035456) | 2.46537430 |
| 142 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.45928132 |
| 143 | erythrocyte maturation (GO:0043249) | 2.44083524 |
| 144 | cellular response to type I interferon (GO:0071357) | 2.42727066 |
| 145 | type I interferon signaling pathway (GO:0060337) | 2.42727066 |
| 146 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.40384616 |
| 147 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.40195981 |
| 148 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40065757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.44478526 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.39309097 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.07826556 |
| 4 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.90170985 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.67973269 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.63928634 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28234596 |
| 8 | * MYC_22102868_ChIP-Seq_BL_Human | 3.16309206 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94846914 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70746103 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70349795 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65710521 |
| 13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.60516086 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54690045 |
| 15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46732173 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.40617343 |
| 17 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39431905 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39103455 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38901901 |
| 20 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37159314 |
| 21 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32683112 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31309796 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30281630 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28453840 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.28104931 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.26037194 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.18231986 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13840254 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 2.13213384 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11763193 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11334583 |
| 32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.09591606 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06643285 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02356232 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00897837 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00453622 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99513446 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98679601 |
| 39 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97829481 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73269688 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67620862 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65135934 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61350786 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60991583 |
| 45 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57748966 |
| 46 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56108671 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53173992 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52811347 |
| 49 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51197481 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49574839 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49396999 |
| 52 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48355625 |
| 53 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47493879 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46684032 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46446181 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44546119 |
| 57 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43451753 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39615593 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38814121 |
| 60 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38735168 |
| 61 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.38328026 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.38309060 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36985083 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.32351531 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29928687 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29245675 |
| 67 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27271883 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25667306 |
| 69 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25557419 |
| 70 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24852203 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24700529 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24613847 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23633481 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21850328 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21159654 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20686985 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19983923 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18928051 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18628820 |
| 80 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18380422 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17484450 |
| 82 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17255947 |
| 83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16625293 |
| 84 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.12952475 |
| 85 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.12615547 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11270347 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09983165 |
| 88 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06241948 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04883738 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04279519 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03661224 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03269512 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02514188 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02219943 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01147655 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99290486 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98136046 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.97186743 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96305952 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96244997 |
| 101 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96042842 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96035320 |
| 103 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95532662 |
| 104 | P300_27268052_Chip-Seq_Bcells_Human | 0.95284896 |
| 105 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95023762 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94286963 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93983165 |
| 108 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92772003 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92639985 |
| 110 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89017844 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88638871 |
| 112 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.87745064 |
| 113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87276013 |
| 114 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87181248 |
| 115 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.86544270 |
| 116 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.86161944 |
| 117 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.85663737 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85329413 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84425367 |
| 120 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83407581 |
| 121 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83407581 |
| 122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83387051 |
| 123 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83190689 |
| 124 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80099916 |
| 125 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.77965538 |
| 126 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77319167 |
| 127 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77227647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.23088890 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.91881761 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.77638905 |
| 4 | MP0004808_abnormal_hematopoietic_stem | 2.61619355 |
| 5 | MP0000685_abnormal_immune_system | 2.48473485 |
| 6 | MP0005671_abnormal_response_to | 2.46605489 |
| 7 | MP0001800_abnormal_humoral_immune | 2.38544041 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.34271764 |
| 9 | MP0003436_decreased_susceptibility_to | 2.33975531 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.33657787 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.19945233 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.18993439 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.15943211 |
| 14 | MP0001873_stomach_inflammation | 2.15451943 |
| 15 | MP0003724_increased_susceptibility_to | 2.14222801 |
| 16 | MP0001853_heart_inflammation | 2.12003541 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.11641962 |
| 18 | * MP0002398_abnormal_bone_marrow | 2.11116365 |
| 19 | MP0001819_abnormal_immune_cell | 2.09601145 |
| 20 | MP0002723_abnormal_immune_serum | 2.09376104 |
| 21 | MP0001790_abnormal_immune_system | 2.06763262 |
| 22 | MP0005387_immune_system_phenotype | 2.06763262 |
| 23 | MP0005025_abnormal_response_to | 2.03893225 |
| 24 | MP0002419_abnormal_innate_immunity | 1.93149939 |
| 25 | MP0009785_altered_susceptibility_to | 1.92302951 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.89792018 |
| 27 | * MP0005397_hematopoietic_system_phenotyp | 1.88247065 |
| 28 | * MP0001545_abnormal_hematopoietic_system | 1.88247065 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.84380731 |
| 30 | MP0002722_abnormal_immune_system | 1.82881691 |
| 31 | MP0002405_respiratory_system_inflammati | 1.82578118 |
| 32 | MP0004947_skin_inflammation | 1.82150686 |
| 33 | * MP0000716_abnormal_immune_system | 1.81784503 |
| 34 | MP0003303_peritoneal_inflammation | 1.80664408 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.80484740 |
| 36 | * MP0000689_abnormal_spleen_morphology | 1.79051553 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.78820603 |
| 38 | MP0000490_abnormal_crypts_of | 1.77817239 |
| 39 | * MP0000465_gastrointestinal_hemorrhage | 1.75148448 |
| 40 | MP0002006_tumorigenesis | 1.73127406 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.71603999 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.63640565 |
| 43 | * MP0002429_abnormal_blood_cell | 1.59364505 |
| 44 | MP0003866_abnormal_defecation | 1.53223699 |
| 45 | MP0006082_CNS_inflammation | 1.50809442 |
| 46 | MP0006054_spinal_hemorrhage | 1.50626793 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.40372749 |
| 48 | * MP0009278_abnormal_bone_marrow | 1.37607921 |
| 49 | MP0001851_eye_inflammation | 1.34772755 |
| 50 | MP0002933_joint_inflammation | 1.32415377 |
| 51 | MP0003279_aneurysm | 1.31954420 |
| 52 | MP0000858_altered_metastatic_potential | 1.30742034 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.30119277 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.29020606 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.27907468 |
| 56 | MP0003828_pulmonary_edema | 1.26435283 |
| 57 | MP0003448_altered_tumor_morphology | 1.25429773 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.25235443 |
| 59 | MP0008007_abnormal_cellular_replicative | 1.24759032 |
| 60 | MP0005023_abnormal_wound_healing | 1.24240948 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.18930720 |
| 62 | MP0004510_myositis | 1.17873892 |
| 63 | MP0002009_preneoplasia | 1.17167408 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.16480136 |
| 65 | MP0002060_abnormal_skin_morphology | 1.13484295 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.12190081 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.03575990 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.03297908 |
| 69 | MP0009764_decreased_sensitivity_to | 1.01447847 |
| 70 | MP0003943_abnormal_hepatobiliary_system | 0.98041237 |
| 71 | MP0008469_abnormal_protein_level | 0.97898899 |
| 72 | MP0000383_abnormal_hair_follicle | 0.97165450 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.97165392 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.97048318 |
| 75 | MP0001216_abnormal_epidermal_layer | 0.96918061 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.96749369 |
| 77 | MP0008057_abnormal_DNA_replication | 0.95513862 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.94736063 |
| 79 | MP0000343_altered_response_to | 0.94020656 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.93023010 |
| 81 | MP0002254_reproductive_system_inflammat | 0.92390794 |
| 82 | MP0008995_early_reproductive_senescence | 0.91486953 |
| 83 | MP0002132_abnormal_respiratory_system | 0.89803020 |
| 84 | MP0010307_abnormal_tumor_latency | 0.89694038 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.89658234 |
| 86 | MP0008004_abnormal_stomach_pH | 0.88149226 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.87948839 |
| 88 | MP0003693_abnormal_embryo_hatching | 0.87919373 |
| 89 | MP0003077_abnormal_cell_cycle | 0.85589058 |
| 90 | MP0004381_abnormal_hair_follicle | 0.84860545 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.84667745 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.83851288 |
| 93 | MP0002095_abnormal_skin_pigmentation | 0.83676485 |
| 94 | MP0009840_abnormal_foam_cell | 0.82033552 |
| 95 | MP0005390_skeleton_phenotype | 0.80402223 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.80131169 |
| 97 | MP0001191_abnormal_skin_condition | 0.79268528 |
| 98 | MP0005310_abnormal_salivary_gland | 0.78622427 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.76694027 |
| 100 | * MP0009931_abnormal_skin_appearance | 0.76299752 |
| 101 | MP0005166_decreased_susceptibility_to | 0.76064462 |
| 102 | MP0010094_abnormal_chromosome_stability | 0.74652141 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.73108140 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.72962240 |
| 105 | MP0008260_abnormal_autophagy | 0.72930697 |
| 106 | MP0003795_abnormal_bone_structure | 0.72721621 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.72502835 |
| 108 | MP0001243_abnormal_dermal_layer | 0.72363487 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.72136065 |
| 110 | MP0003075_altered_response_to | 0.71873245 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.71519682 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.70604643 |
| 113 | MP0002796_impaired_skin_barrier | 0.69407316 |
| 114 | MP0001663_abnormal_digestive_system | 0.68945657 |
| 115 | MP0000249_abnormal_blood_vessel | 0.65393924 |
| 116 | MP0004883_abnormal_blood_vessel | 0.65150913 |
| 117 | MP0002928_abnormal_bile_duct | 0.62817932 |
| 118 | MP0009763_increased_sensitivity_to | 0.61995714 |
| 119 | MP0010678_abnormal_skin_adnexa | 0.61985216 |
| 120 | MP0008873_increased_physiological_sensi | 0.61864006 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.60733454 |
| 122 | MP0009379_abnormal_foot_pigmentation | 0.60045481 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.56445689 |
| 124 | MP0005535_abnormal_body_temperature | 0.54971200 |
| 125 | MP0005164_abnormal_response_to | 0.52566667 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.52563366 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.51190566 |
| 128 | MP0001881_abnormal_mammary_gland | 0.51027499 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.50183130 |
| 130 | MP0005451_abnormal_body_composition | 0.48941657 |
| 131 | MP0001764_abnormal_homeostasis | 0.48580090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 4.10476308 |
| 2 | IgM deficiency (HP:0002850) | 4.00295686 |
| 3 | Prolonged bleeding time (HP:0003010) | 3.99974618 |
| 4 | Myositis (HP:0100614) | 3.95717420 |
| 5 | Chronic otitis media (HP:0000389) | 3.80112790 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76217248 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 3.73282014 |
| 8 | Petechiae (HP:0000967) | 3.41014345 |
| 9 | Abnormal platelet function (HP:0011869) | 3.29030571 |
| 10 | Impaired platelet aggregation (HP:0003540) | 3.29030571 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.28514502 |
| 12 | Recurrent viral infections (HP:0004429) | 3.20107941 |
| 13 | Cellulitis (HP:0100658) | 3.16505602 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.13098365 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.10064800 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08917439 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.08824817 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.04731752 |
| 19 | Epistaxis (HP:0000421) | 3.04003434 |
| 20 | Abnormality of the fingertips (HP:0001211) | 3.00231656 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 3.00009539 |
| 22 | Orchitis (HP:0100796) | 2.98396977 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 2.98046308 |
| 24 | Spinal cord lesions (HP:0100561) | 2.92256603 |
| 25 | Syringomyelia (HP:0003396) | 2.92256603 |
| 26 | Seborrheic dermatitis (HP:0001051) | 2.89139014 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.87184509 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 2.84036089 |
| 29 | Abnormality of T cells (HP:0002843) | 2.78872476 |
| 30 | Abnormal platelet volume (HP:0011876) | 2.78522141 |
| 31 | Pustule (HP:0200039) | 2.78172612 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.77359364 |
| 33 | Combined immunodeficiency (HP:0005387) | 2.75444970 |
| 34 | T lymphocytopenia (HP:0005403) | 2.73830222 |
| 35 | Acute myeloid leukemia (HP:0004808) | 2.73558477 |
| 36 | Increased IgM level (HP:0003496) | 2.73240037 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.71500450 |
| 38 | Stomach cancer (HP:0012126) | 2.70733918 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 2.70094038 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 2.70022389 |
| 41 | Urticaria (HP:0001025) | 2.70010557 |
| 42 | Verrucae (HP:0200043) | 2.68302159 |
| 43 | Papilloma (HP:0012740) | 2.68302159 |
| 44 | Hypertensive crisis (HP:0100735) | 2.68278736 |
| 45 | Reticulocytopenia (HP:0001896) | 2.67562989 |
| 46 | Arterial thrombosis (HP:0004420) | 2.66949649 |
| 47 | Increased IgE level (HP:0003212) | 2.66776567 |
| 48 | Meningitis (HP:0001287) | 2.65559165 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65053259 |
| 50 | Nasal polyposis (HP:0100582) | 2.63818387 |
| 51 | Episodic fever (HP:0001954) | 2.60562238 |
| 52 | Abnormality of the nasal mucosa (HP:0000433) | 2.59884567 |
| 53 | Gingival bleeding (HP:0000225) | 2.57056260 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.55003009 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.53251607 |
| 56 | Optic neuritis (HP:0100653) | 2.52842289 |
| 57 | Retrobulbar optic neuritis (HP:0100654) | 2.52842289 |
| 58 | Hematochezia (HP:0002573) | 2.51400207 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.46071309 |
| 60 | Prostate neoplasm (HP:0100787) | 2.43102717 |
| 61 | Periodontitis (HP:0000704) | 2.39870655 |
| 62 | Colitis (HP:0002583) | 2.36694716 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.34987261 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.34448602 |
| 65 | Chest pain (HP:0100749) | 2.34392780 |
| 66 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.33592466 |
| 67 | Vasculitis (HP:0002633) | 2.33582296 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33408510 |
| 69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33408510 |
| 70 | Increased mean platelet volume (HP:0011877) | 2.31147332 |
| 71 | Recurrent skin infections (HP:0001581) | 2.27718197 |
| 72 | Thyroiditis (HP:0100646) | 2.25509908 |
| 73 | Leukocytosis (HP:0001974) | 2.22325716 |
| 74 | Menorrhagia (HP:0000132) | 2.20970197 |
| 75 | Metaphyseal dysplasia (HP:0100255) | 2.20946442 |
| 76 | Increased serum ferritin (HP:0003281) | 2.19298960 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.19106537 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 2.18525562 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18525562 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 2.17844655 |
| 81 | Gingivitis (HP:0000230) | 2.17056057 |
| 82 | Sepsis (HP:0100806) | 2.15722990 |
| 83 | Aplastic anemia (HP:0001915) | 2.15644642 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14837706 |
| 85 | Obstructive lung disease (HP:0006536) | 2.14837706 |
| 86 | Spondylolisthesis (HP:0003302) | 2.13938396 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 2.12711006 |
| 88 | Lymphopenia (HP:0001888) | 2.12186188 |
| 89 | Encephalitis (HP:0002383) | 2.11355600 |
| 90 | Skin rash (HP:0000988) | 2.11065338 |
| 91 | Pallor (HP:0000980) | 2.10906270 |
| 92 | Increased density of long bones (HP:0006392) | 2.06147812 |
| 93 | Joint swelling (HP:0001386) | 2.02923110 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02902452 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.02847704 |
| 96 | Aortic aneurysm (HP:0004942) | 2.02719060 |
| 97 | Purpura (HP:0000979) | 2.02105853 |
| 98 | Skin ulcer (HP:0200042) | 2.00381725 |
| 99 | Hemoptysis (HP:0002105) | 1.99436550 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.99196372 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.99130539 |
| 102 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98649774 |
| 103 | Chronic diarrhea (HP:0002028) | 1.95921181 |
| 104 | Amaurosis fugax (HP:0100576) | 1.95604772 |
| 105 | B lymphocytopenia (HP:0010976) | 1.94567156 |
| 106 | Abnormality of B cell number (HP:0010975) | 1.94567156 |
| 107 | Bruising susceptibility (HP:0000978) | 1.94230043 |
| 108 | Increased cerebral lipofuscin (HP:0011813) | 1.93613965 |
| 109 | Alveolar cell carcinoma (HP:0006519) | 1.93019441 |
| 110 | Lymphoma (HP:0002665) | 1.92608670 |
| 111 | Growth hormone excess (HP:0000845) | 1.92186225 |
| 112 | Abnormality of male internal genitalia (HP:0000022) | 1.91959726 |
| 113 | Myelodysplasia (HP:0002863) | 1.91935680 |
| 114 | Acute lymphatic leukemia (HP:0006721) | 1.90025916 |
| 115 | IgG deficiency (HP:0004315) | 1.89903996 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.89328804 |
| 117 | IgA deficiency (HP:0002720) | 1.88152163 |
| 118 | Abnormality of the columella (HP:0009929) | 1.86663388 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 1.86031285 |
| 120 | Abnormality of eosinophils (HP:0001879) | 1.85623146 |
| 121 | Osteomyelitis (HP:0002754) | 1.85429382 |
| 122 | Vertigo (HP:0002321) | 1.85057633 |
| 123 | Granulocytopenia (HP:0001913) | 1.82991767 |
| 124 | Abnormality of macrophages (HP:0004311) | 1.81728219 |
| 125 | Fatigue (HP:0012378) | 1.80731436 |
| 126 | Eosinophilia (HP:0001880) | 1.80251254 |
| 127 | 11 pairs of ribs (HP:0000878) | 1.78045462 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.76088875 |
| 129 | Pulmonary embolism (HP:0002204) | 1.75826841 |
| 130 | Autoimmune hemolytic anemia (HP:0001890) | 1.75685011 |
| 131 | Stomatitis (HP:0010280) | 1.74763491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.12257754 |
| 2 | EEF2K | 3.39757195 |
| 3 | TGFBR2 | 2.65217833 |
| 4 | TXK | 2.57759460 |
| 5 | MAP2K3 | 2.38654098 |
| 6 | STK10 | 2.36653180 |
| 7 | KIT | 2.24766109 |
| 8 | JAK3 | 2.23256885 |
| 9 | MAP3K11 | 2.18491573 |
| 10 | BTK | 2.09881154 |
| 11 | ZAP70 | 1.96801515 |
| 12 | TEC | 1.93192879 |
| 13 | PRPF4B | 1.92617468 |
| 14 | PKN2 | 1.88862442 |
| 15 | TRIB3 | 1.83384258 |
| 16 | SCYL2 | 1.80931094 |
| 17 | MAP3K13 | 1.80758346 |
| 18 | TYK2 | 1.76460933 |
| 19 | TGFBR1 | 1.63644766 |
| 20 | NME2 | 1.61771949 |
| 21 | ITK | 1.59655284 |
| 22 | LRRK2 | 1.57117118 |
| 23 | RPS6KA4 | 1.55318459 |
| 24 | IRAK4 | 1.52744048 |
| 25 | TBK1 | 1.52361262 |
| 26 | ERN1 | 1.51290564 |
| 27 | IKBKE | 1.51129371 |
| 28 | BLK | 1.50990744 |
| 29 | CSF1R | 1.49874467 |
| 30 | MAP3K10 | 1.49454964 |
| 31 | RPS6KB2 | 1.49147813 |
| 32 | IRAK3 | 1.45592795 |
| 33 | RIPK4 | 1.43894385 |
| 34 | TESK2 | 1.42921133 |
| 35 | FLT3 | 1.42177165 |
| 36 | MAP3K14 | 1.37714106 |
| 37 | TRPM7 | 1.31784599 |
| 38 | PIM1 | 1.31432942 |
| 39 | GRK6 | 1.30336528 |
| 40 | IKBKB | 1.29024113 |
| 41 | FGFR3 | 1.27691613 |
| 42 | BCKDK | 1.25534823 |
| 43 | HCK | 1.23110383 |
| 44 | SYK | 1.19481657 |
| 45 | LCK | 1.15879563 |
| 46 | MAP3K3 | 1.15435218 |
| 47 | NLK | 1.15104862 |
| 48 | CDK6 | 1.09638792 |
| 49 | CLK1 | 1.08995390 |
| 50 | DYRK1B | 1.07893488 |
| 51 | MAPK7 | 1.07734599 |
| 52 | MAP3K1 | 1.05398895 |
| 53 | EPHB1 | 1.05311392 |
| 54 | TNK2 | 1.03959340 |
| 55 | FGFR4 | 1.03155668 |
| 56 | TAOK3 | 1.01772765 |
| 57 | MAPKAPK3 | 1.00765240 |
| 58 | MATK | 1.00367655 |
| 59 | CSK | 0.99087143 |
| 60 | CHUK | 0.98562047 |
| 61 | PTK6 | 0.94981177 |
| 62 | CDK12 | 0.93941097 |
| 63 | NUAK1 | 0.93876845 |
| 64 | TIE1 | 0.92622964 |
| 65 | PIM2 | 0.90327583 |
| 66 | JAK1 | 0.88655910 |
| 67 | HIPK2 | 0.87281217 |
| 68 | TAOK2 | 0.85562547 |
| 69 | SIK3 | 0.84574506 |
| 70 | CDK4 | 0.84046255 |
| 71 | PRKCQ | 0.81310461 |
| 72 | RPS6KA6 | 0.78769385 |
| 73 | MAPKAPK5 | 0.78072015 |
| 74 | MST4 | 0.77442800 |
| 75 | VRK2 | 0.76587769 |
| 76 | JAK2 | 0.73989170 |
| 77 | LYN | 0.73944514 |
| 78 | CAMK1D | 0.73408588 |
| 79 | FES | 0.72615794 |
| 80 | CDK9 | 0.72134490 |
| 81 | MAPK12 | 0.68015171 |
| 82 | MKNK1 | 0.67468105 |
| 83 | PASK | 0.67058720 |
| 84 | RPS6KC1 | 0.66750294 |
| 85 | RPS6KL1 | 0.66750294 |
| 86 | PRKD2 | 0.66065364 |
| 87 | PAK4 | 0.65178439 |
| 88 | NEK9 | 0.64122486 |
| 89 | MAPK4 | 0.63947421 |
| 90 | MAP2K2 | 0.61261698 |
| 91 | MAP3K6 | 0.61237784 |
| 92 | SMG1 | 0.60302772 |
| 93 | MAPKAPK2 | 0.59316667 |
| 94 | STK4 | 0.57938134 |
| 95 | TTN | 0.52961824 |
| 96 | STK24 | 0.52615759 |
| 97 | MAPK15 | 0.51528924 |
| 98 | MAP3K8 | 0.51260043 |
| 99 | NEK2 | 0.51178511 |
| 100 | CDK7 | 0.50979142 |
| 101 | SIK1 | 0.50587626 |
| 102 | MAP4K2 | 0.50566785 |
| 103 | RIPK1 | 0.50473928 |
| 104 | TSSK6 | 0.49143430 |
| 105 | BMPR2 | 0.48932404 |
| 106 | TAOK1 | 0.47735058 |
| 107 | MAP3K7 | 0.44213201 |
| 108 | DYRK3 | 0.43739428 |
| 109 | EPHA3 | 0.43232616 |
| 110 | CDK8 | 0.43177266 |
| 111 | IRAK1 | 0.42296186 |
| 112 | MARK2 | 0.42002027 |
| 113 | MAPK3 | 0.41943859 |
| 114 | KDR | 0.41640019 |
| 115 | PDK1 | 0.40932458 |
| 116 | PAK2 | 0.40882738 |
| 117 | RPS6KA5 | 0.39796487 |
| 118 | STK3 | 0.39651462 |
| 119 | MARK3 | 0.39351850 |
| 120 | MAP2K6 | 0.39200023 |
| 121 | SIK2 | 0.38460169 |
| 122 | PIK3CG | 0.37805735 |
| 123 | MKNK2 | 0.37728271 |
| 124 | PDGFRB | 0.37170589 |
| 125 | PIK3CA | 0.36997494 |
| 126 | FYN | 0.36870171 |
| 127 | MAPK11 | 0.36752081 |
| 128 | STK38 | 0.36290013 |
| 129 | PRKCD | 0.35512141 |
| 130 | MELK | 0.34608558 |
| 131 | PRKD1 | 0.30611315 |
| 132 | RPS6KA2 | 0.29876377 |
| 133 | ABL1 | 0.28822044 |
| 134 | PRKG2 | 0.25684817 |
| 135 | IGF1R | 0.24397555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.83419003 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.54255515 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48293799 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.23153346 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16147141 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14759014 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09262504 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.04744346 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99485756 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96789571 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95700504 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93009510 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69585863 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69049375 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68848273 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.65522537 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63526707 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62357968 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.59579383 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58468930 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57554166 |
| 22 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.57172858 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49204232 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44141981 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43164087 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.41226567 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40280151 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38958632 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.37915652 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37483627 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32657430 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.31935157 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.31704539 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29701358 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29213997 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.26868411 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 1.26105189 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22979883 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.21680018 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.19713564 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.19307291 |
| 42 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.18215966 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12049872 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11690845 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.09617987 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08793548 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03612714 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 1.02923685 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02803567 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.00433100 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00310089 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99715966 |
| 53 | Spliceosome_Homo sapiens_hsa03040 | 0.97190772 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96517744 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96206028 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95227955 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.94739772 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94273292 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93544274 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88075714 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85948864 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85906277 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84138673 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83885601 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.81965196 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81651718 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.81092855 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80894154 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80608872 |
| 70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80475166 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.80332275 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79662221 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78984173 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78181948 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77626382 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75254317 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75032790 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74686720 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73007760 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71885675 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.70937435 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69143541 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.68792598 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68270061 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.65917474 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65217677 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63661311 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63030573 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62863101 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62222633 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61083108 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60428859 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59517372 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58966524 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58909385 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58867162 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.57131718 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56827343 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56658671 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55967793 |
| 101 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55940642 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54568044 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.51695045 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.51485485 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50725597 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.50264030 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45645098 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44928877 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43839328 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42521052 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.41023164 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.40847467 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.40794297 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40048344 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39495158 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38534424 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37022294 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36189829 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36046945 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.35940598 |
| 121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35355229 |
| 122 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34955417 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.34810789 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34787843 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29711987 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28818149 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23211479 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.22799610 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.19988037 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19476812 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17616403 |

